OBSOLETE: Short chain 3-hydroxyacyl-CoA dehydrogenase deficiency
short cheyn three hahy-drok-see-uh-sil koh-uh dee-hahy-droh-juh-neys dih-fish-uhn-see
Also known as: SCHAD deficiency, Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency
At a Glance
What is OBSOLETE: Short chain 3-hydroxyacyl-CoA dehydrogenase deficiency?
Short chain 3-hydroxyacyl-CoA dehydrogenase deficiency is a rare metabolic disorder affecting the body's ability to break down certain fats. This condition primarily affects the liver, muscles, and brain. It is caused by mutations in the HADH gene, leading to a deficiency in an enzyme needed for fat metabolism. Over time, individuals may experience episodes of low blood sugar, muscle weakness, and developmental delays. Early symptoms often include poor feeding, lethargy, and vomiting, while later symptoms can involve more severe metabolic crises. Early diagnosis is crucial to manage symptoms and prevent complications. The condition can place a significant emotional and financial burden on families due to the need for ongoing medical care. With proper management, individuals can lead relatively normal lives, although they may need to avoid fasting and adhere to a special diet. Prognosis varies, but early intervention can improve outcomes. Daily life may involve regular medical check-ups and dietary adjustments. Support from healthcare providers and patient organizations can be invaluable. Despite challenges, many affected individuals achieve developmental milestones with appropriate care.
Medical Definition
Short chain 3-hydroxyacyl-CoA dehydrogenase deficiency is a genetic disorder characterized by a defect in the HADH gene, resulting in impaired fatty acid oxidation. Pathologically, this leads to an accumulation of medium-chain fatty acids, causing hypoglycemia and metabolic crises. Histological findings may include steatosis in liver tissues due to fat accumulation. It is classified under fatty acid oxidation disorders, with a primary impact on energy metabolism. Epidemiologically, it is considered extremely rare, with few documented cases worldwide. The disease course can vary, with some individuals experiencing severe metabolic crises while others have milder symptoms managed through dietary interventions.
OBSOLETE: Short chain 3-hydroxyacyl-CoA dehydrogenase deficiency Symptoms
Symptoms vary in severity between individuals. Early diagnosis and management can significantly improve outcomes.
Very Common
Hypoglycemia manifests as low blood sugar levels, leading to symptoms such as shakiness, sweating, and confusion. It is caused by the body's inability to properly break down short-chain fatty acids for energy. Over time, recurrent episodes can lead to neurological damage if not managed appropriately. Patients need to monitor their blood sugar levels regularly and may require dietary modifications to prevent episodes.
Muscle weakness presents as a reduced ability to exert force with muscles, often leading to fatigue and difficulty in performing physical tasks. This occurs due to insufficient energy production from fatty acids, which are crucial for muscle function. If untreated, muscle weakness can worsen, impacting mobility and overall physical activity. Physical therapy and a tailored exercise regimen can help manage this symptom.
Lethargy is characterized by a persistent feeling of tiredness and lack of energy, affecting daily activities and alertness. It results from the body's inability to efficiently convert fatty acids into energy, leading to energy deficits. Over time, lethargy can contribute to decreased quality of life and may exacerbate other symptoms. Ensuring adequate nutrition and managing energy intake can help alleviate this symptom.
Common
Vomiting is the forceful expulsion of stomach contents, often accompanied by nausea and abdominal discomfort. It can occur due to metabolic imbalances caused by the accumulation of unmetabolized fatty acids. Repeated episodes can lead to dehydration and electrolyte imbalances if not addressed. Maintaining hydration and dietary adjustments can help manage this symptom.
Failure to thrive is observed as poor weight gain and growth in infants and children, often due to inadequate caloric intake or absorption. The metabolic block in fatty acid oxidation leads to insufficient energy availability for growth. If not managed, it can result in developmental delays and growth retardation. Nutritional support and regular monitoring of growth parameters are essential for management.
Hepatomegaly is the abnormal enlargement of the liver, which can be detected through physical examination or imaging. It occurs due to the accumulation of fatty acids and other metabolites in the liver. Over time, this can lead to liver dysfunction if not properly managed. Regular monitoring of liver function tests and dietary modifications can help manage this condition.
Less Common
Cardiomyopathy is a disease of the heart muscle that can lead to heart failure, arrhythmias, and other cardiac complications. It is caused by the energy deficiency in cardiac muscle cells due to impaired fatty acid oxidation. If left untreated, it can progress to severe cardiac dysfunction. Regular cardiac evaluations and appropriate medical management are crucial for patients with this symptom.
Developmental delay refers to slower than expected progress in achieving developmental milestones such as walking and talking. It is linked to energy deficits affecting brain development and function. Without intervention, developmental delays can impact cognitive and motor skills long-term. Early intervention programs and supportive therapies can help improve outcomes for affected individuals.
What Causes OBSOLETE: Short chain 3-hydroxyacyl-CoA dehydrogenase deficiency?
Short chain 3-hydroxyacyl-CoA dehydrogenase deficiency is caused by mutations in the HADH gene located on chromosome 4q25. The HADH gene encodes the enzyme 3-hydroxyacyl-CoA dehydrogenase, which is crucial for the beta-oxidation of fatty acids in mitochondria. Mutations in the HADH gene can lead to structural changes in the enzyme, impairing its ability to catalyze the conversion of 3-hydroxyacyl-CoA to 3-ketoacyl-CoA. This disruption results in the accumulation of intermediate metabolites and a reduction in energy production within the mitochondria. As mitochondria are the powerhouses of the cell, their dysfunction can lead to energy deficits, particularly affecting high-energy demanding tissues such as the brain and muscles. The accumulation of toxic metabolites can also induce oxidative stress, further damaging cellular components. Neuroinflammation may be triggered as the immune system responds to cellular distress signals, exacerbating neuronal damage. White matter degeneration occurs as oligodendrocytes, responsible for myelination, are affected by the metabolic imbalance. Symptoms such as hypotonia, developmental delay, and seizures appear due to the vulnerability of the central nervous system to energy deficits and structural damage. The pattern of symptoms is influenced by the specific regions of the brain affected and the degree of metabolic disruption. Disease severity varies between patients due to differences in the specific mutations, residual enzyme activity, and compensatory metabolic pathways. Some patients may have milder forms of the disease if alternative pathways partially compensate for the enzymatic deficiency. Environmental factors and additional genetic modifiers can also influence the clinical presentation. Early detection and management are crucial to mitigate the effects of this metabolic disorder.
How is OBSOLETE: Short chain 3-hydroxyacyl-CoA dehydrogenase deficiency Diagnosed?
Typical age of diagnosis: Diagnosis typically occurs in infancy or early childhood when symptoms such as hypoglycemia, lethargy, and muscle weakness become apparent, often triggered by fasting or illness.
The clinician looks for signs of metabolic crisis, including hypoglycemia and muscle weakness. A detailed family history is taken to identify any relatives with similar metabolic disorders. Physical examination may reveal hypotonia and hepatomegaly. This step helps to determine the need for further metabolic and genetic testing.
An abdominal ultrasound is often used to assess liver size and structure. Hepatomegaly may be visible, supporting a metabolic disorder diagnosis. Imaging helps exclude other causes of liver enlargement such as tumors or infections. However, imaging alone cannot confirm the diagnosis of this specific deficiency.
Blood tests are ordered to measure acylcarnitine profiles and organic acids. Elevated levels of specific short-chain acylcarnitines indicate a possible enzymatic deficiency. Abnormal results suggest a defect in fatty acid oxidation, prompting further genetic testing. These results guide the clinician in tailoring dietary and medical interventions.
Genetic testing involves sequencing the HADH gene, which encodes the enzyme short-chain 3-hydroxyacyl-CoA dehydrogenase. Mutations such as missense or nonsense mutations are identified. Positive results confirm the diagnosis and provide a basis for genetic counseling. This information is crucial for advising family members about carrier status and prenatal testing options.
OBSOLETE: Short chain 3-hydroxyacyl-CoA dehydrogenase deficiency Treatment Options
MCT oil is used as a dietary supplement to provide an alternative energy source. It bypasses the defective enzyme pathway, allowing for better energy production. Clinical evidence suggests improved metabolic stability with MCT supplementation. Limitations include gastrointestinal side effects and the need for careful dietary management. Regular monitoring of metabolic parameters is necessary to adjust dosages.
Techniques focus on improving muscle strength and coordination. The goal is to enhance motor function and reduce muscle weakness. Sessions are typically conducted 2-3 times per week, lasting 30-60 minutes each. Outcomes are measured by improvements in muscle tone and motor milestones. Long-term benefits include increased independence and quality of life.
Indicated in cases of severe liver dysfunction unresponsive to medical management. The procedure involves replacing the diseased liver with a healthy donor liver. Expected benefits include normalization of metabolic function and prevention of metabolic crises. Surgical risks include rejection and infection, requiring lifelong immunosuppression. Post-operative care involves regular follow-up and monitoring of liver function.
The care team includes metabolic specialists, dietitians, physical therapists, and genetic counselors. Interventions focus on dietary management, physical rehabilitation, and genetic counseling. Psychosocial support strategies include counseling for patients and families to cope with chronic illness. Family education is provided on managing metabolic crises and recognizing symptoms. Long-term monitoring involves regular follow-up visits to adjust treatment plans as needed.
When to See a Doctor for OBSOLETE: Short chain 3-hydroxyacyl-CoA dehydrogenase deficiency
- Severe hypoglycemia — This is an emergency because it can lead to seizures, coma, or even death if not treated promptly.
- Acute metabolic crisis — This is an emergency as it can cause rapid deterioration of vital functions and requires immediate medical intervention.
- Severe muscle weakness or hypotonia — This is an emergency because it can affect breathing and other critical bodily functions.
- Persistent vomiting — This is concerning as it may indicate metabolic imbalance; contact your healthcare provider for advice.
- Lethargy or fatigue — This is significant as it may suggest an underlying metabolic issue that needs evaluation.
- Failure to thrive in infants — This is concerning as it may indicate inadequate energy production; seek medical assessment.
- Mild muscle cramps — Monitor for worsening symptoms and ensure adequate hydration and nutrition.
- Occasional irritability — Monitor for patterns and consider discussing with a healthcare provider if it persists.
OBSOLETE: Short chain 3-hydroxyacyl-CoA dehydrogenase deficiency — Frequently Asked Questions
Is this condition hereditary?
Short chain 3-hydroxyacyl-CoA dehydrogenase deficiency is inherited in an autosomal recessive pattern. This means both parents must carry one copy of the mutated gene to pass it to their child. The probability of passing the condition to children is 25% if both parents are carriers. De novo mutations are rare in this condition. Genetic counseling is recommended for families to understand carrier status and reproductive options.
What is the life expectancy for someone with this condition?
Life expectancy varies depending on the age of onset and severity of symptoms. Early diagnosis and management can improve outcomes significantly. Mortality is often related to metabolic crises or complications from hypoglycemia. Effective treatment and dietary management can enhance survival and quality of life. Realistic expectations should include regular medical follow-up and lifestyle adjustments.
How is this condition diagnosed and how long does diagnosis take?
Diagnosis involves a combination of clinical evaluation, biochemical tests, and genetic testing. The time from first symptoms to diagnosis can vary, often taking weeks to months. Specialists such as metabolic geneticists and pediatricians are typically involved. Delays in diagnosis may occur due to the rarity of the condition and nonspecific early symptoms. Confirmation is usually achieved through genetic testing identifying mutations in the HADH gene.
Are there any new treatments or clinical trials available?
Current research is exploring gene therapy and enzyme replacement as potential treatments. Novel approaches like these are still in experimental stages. ClinicalTrials.gov is a resource for finding ongoing trials related to this condition. Discuss with your doctor about the possibility of participating in trials and the potential benefits and risks. New treatments may take several years to become widely available.
How does this condition affect daily life and activities?
The condition can impact mobility and self-care, especially during metabolic crises. Educational implications may include the need for individualized learning plans. Social and emotional challenges can arise due to the chronic nature of the condition and its management. The family may experience a significant burden due to care requirements and medical appointments. Supports such as dietary management and adaptive equipment can greatly assist in daily living.
Support & Resources
This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.Last reviewed: 2026-04-27